HOME         WEBSITE         SUBSCRIBE           E-GREETINGS   
                               

Tuesday, May 12, 2015

Implemention of Rashtriya Arogya Nidhi (RAN)

The Rashtriya Arogya Nidhi (RAN) is under implementation in the country. Details of scheme and salient features are given below:- 

The Rashtriya Arogya Nidhi (RAN) has been set up vide Resolution No. F-7-2/96-Fin-II dated 13/1/1997 and registered under the Societies Registration Act, 1860, as a Society. The RAN was set up to provide financial assistance to patients, living below poverty line and who are suffering from major life threatening diseases, to receive medical treatment at any of the super speciality Hospitals/Institutes or other Government hospitals. The financial assistance to such patients is released in the form of ‘one-time grant', which is released to the Medical Superintendent of the Hospital in which the treatment has been/is being received. 

The RAN is operationalized through four windows, detailed below: 

(i) Revolving Funds have been set up in 12 Central Government Hospitals/Institutions located all over India for providing financial assistance for treatment upto Rs. 2 lakh. 

(ii) Financial assistance is provided from RAN Headquarters for cases referred by Government hospitals/institutions, which do not have a Revolving Fund and for cases referred by 12 Government hospitals/institutions with Revolving Funds for assistance exceeding Rs. 2 lakh. 

(iii) State Illness Assistance Fund set up in all States/UTs (with Legislature) except Meghalaya and Nagaland. Grants-in-aid to States/UTs is released to the extent of 50% of the contributions made by the State Governments/UTs to the State Fund/Society subject to a maximum of Rs. 5 crore to States with larger number and percentage of population below poverty line viz. Andhra Pradesh, Bihar, Madhya Pradesh, Karnataka, Maharashtra, Odisha, Rajasthan, Tamil Nadu, Uttar Pradesh and West Bengal and Rs. 2 crore to other States/UTs. Funds to the States/UTs are released on submission of utilization certificate and list of beneficiaries in respect of funds released to them earlier. 

(iv) Health Minister's Cancer Patient Fund (HMCPF) within RAN which has been established as a separate Corpus Fund, and is also managed by the Managing Committee and Technical Committee of RAN. An amount of Rs. 100.00 crore has been placed in the Corpus Fund and the earning from the Corpus Fund accrued out of interest is utilized for providing financial assistance to cancer patients through 27 Regional Cancer Centres (RCC) located all over India. Revolving Funds have been set up in these RCCs by placing an amount upto Rs. 50 lakh for providing financial assistance for treatment upto Rs. 2 lakh. Cases involving expenditure over and above Rs. 2 lakh, are referred to the Ministry. Funds to the RCCs are released on submission of utilization certificate and list of beneficiaries in respect of funds released to them earlier. 
Posted by

Blog Archive

____________________________________________________________________________________________

Disclaimer - All investments in Mutual Funds and securities are subject to market risks and uncertainty of dividend distributions and the NAV of schemes may go up or down depending upon factors and forces affecting securities markets generally. The past performance of the schemes is not necessarily indicative of the future performance and may not necessarily provide a basis for comparison with other investments. Investors are advised to go through the respective offer documents before making any investment decisions. Prospective client(s) are advised to go through all comparable products in offer before taking any investment decisions. Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the fund will be achieved. Information gathered & material used in this document is believed to be from reliable sources. Decisions based on the information provided on this newsletter/document are for your own account and risk.


In the preparation of the material contained in this document, Varun Vaid has used information that is publicly available, including information developed in-house. Some of the material used in the document may have been obtained from members/persons other than the Varun Vaid and which may have been made available to Varun Vaid. Information gathered & material used in this document is believed to be from reliable sources. Varun Vaid however does not warrant the accuracy, reasonableness and/or completeness of any information. For data reference to any third party in this material no such party will assume any liability for the same. Varun Vaid does not in any way through this material solicit any offer for purchase, sale or any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice.


Varun Vaid, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of this material in any manner. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. All recipients of this material should before dealing and/or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investigating in any product/financial instruments should do soon the basis of and after verifying the terms attached to such product/financial instrument. Financial products and instruments are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products and instruments does not necessarily indicate the future prospects and performance there of. Such past performance may or may not be sustained in future. Varun Vaid, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial instruments/products/commodities discussed here in or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The said person may have acted upon and/or in a manner contradictory with the information contained here. No part of this material may be duplicated in whole or in part in any form and or redistributed without the prior written consent of Varun Vaid. This material is strictly confidential to the recipient and should not be reproduced or disseminated to anyone else.


Varun Vaid also does not take any responsibility for the contents of the advertisements published. Readers are advised to verify the contents on their own before acting there upon.


Published Credits goes to following sources & all the mentioned sources as footer below the published material- Bloomberg, Valueresearch Online, Capital Market, Navindia, Franklin Templeton, Kitco, SBI AMC, LIC AMC, JM Financial AMC, HDFC AMC, The Hindu, Business Line, Personal FN, Economic Times, Reuters, Outlook Money, Business Standard, Times of India etc.